Skip to content

Venture capital

Page 4



Blackbird’s valuation adjustments for Culture Amp and SafetyCulture show how shifting markets shape venture values, and why write-downs aren’t always bad news.



We have world-class research and clinical trial strength, but risk aversion and limited capital are holding us back in biotech. Unlocking our potential requires bold investment.







Block is doubling down on Bitcoin, aiming to transform it from a volatile asset into a practical payment system for everyday transactions.







The government says “equity is foundational”. For the women who built a program to prove it, it’s become another disappointing lesson in who really holds power.








Tenmile’s evergreen model keeps returns in the fund, backing new generations of Australian life sciences startups instead of paying out investors.



Australia has the brains and grit to compete globally, but not the speed. To win capital, founders must ditch comfort and move with US-level urgency.
















The AI boom is reshaping venture capital, with massive Silicon Valley funding rounds leaving Australia’s smaller funds looking to find their own deep tech edge.


Next page